These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17412566)

  • 1. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
    Pasqualotto AC; Denning DW
    Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidrug resistance in Aspergillus fumigatus.
    Warris A; Weemaes CM; Verweij PE
    N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
    Chen J; Li H; Li R; Bu D; Wan Z
    J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of azole resistance on aspergillosis guidelines.
    Georgiadou SP; Kontoyiannis DP
    Ann N Y Acad Sci; 2012 Dec; 1272():15-22. PubMed ID: 23231710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air.
    Vanhee LM; Perman D; Nelis HJ; Coenye T
    J Microbiol Methods; 2010 May; 81(2):197-9. PubMed ID: 20193715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
    Dannaoui E; Persat F; Borel E; Piens MA; Picot S
    Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone, prednisolone and dexamethasone act on Aspergillus fumigatus in vitro susceptibility to itraconazole.
    Ramondenc I; Pinel C; Parat S; Ambroise-Thomas P; Grillot R
    Microbios; 2001; 104(407):17-26. PubMed ID: 11229654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive aspergillosis with polyarthritis.
    Mekan SF; Saeed O; Khan JA
    Mycoses; 2004 Dec; 47(11-12):518-20. PubMed ID: 15601460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole-resistant central nervous system aspergillosis.
    van der Linden JW; Jansen RR; Bresters D; Visser CE; Geerlings SE; Kuijper EJ; Melchers WJ; Verweij PE
    Clin Infect Dis; 2009 Apr; 48(8):1111-3. PubMed ID: 19272019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
    Patterson TF; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious diseases. Farm fungicides linked to resistance in a human pathogen.
    Enserink M
    Science; 2009 Nov; 326(5957):1173. PubMed ID: 19965440
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed infection with itraconazole-susceptible and-resistant strains of Aspergillus fumigatus: Diagnostic and therapeutic implications.
    Ahmad S; Khan Z
    J Infect Public Health; 2020 Apr; 13(4):664-666. PubMed ID: 32171723
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe Aspergillus keratomycosis treated with itraconazole per os].
    Villard C; Lacroix C; Rabot MH; Rovira JC; Jacquemin JL
    J Fr Ophtalmol; 1989; 12(4):323-5. PubMed ID: 2560784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
    Al-Nakeeb Z; Sudan A; Jeans AR; Gregson L; Goodwin J; Warn PA; Felton TW; Howard SJ; Hope WW
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4146-53. PubMed ID: 22615280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
    Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
    J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.
    Saulsbury FT
    Clin Infect Dis; 2001 May; 32(10):E137-9. PubMed ID: 11317265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole--perspectives for the management of invasive aspergillosis.
    Groll AH
    Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
    Kolwijck E; van der Hoeven H; de Sévaux RG; ten Oever J; Rijstenberg LL; van der Lee HA; Zoll J; Melchers WJ; Verweij PE
    Am J Respir Crit Care Med; 2016 Apr; 193(8):927-9. PubMed ID: 27082535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.